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Sir,
In our study, none of the three tests we used were helpful in
distinguishing between BRCA1 mutation carriers and non-carriers.
There are three possible explanations: first, this may be because
our sample size was small and we had sufficient power to detect
only relatively large differences. Second, there may in fact be no
phenotype for the BRCA1 heterozygote cell that is discernable in
lymphocytes, and cancer predisposition may depend on reduction
to homozygosity in a given cell; and third, as Vogel and Surowy
point out, our panel of tests may not have been sufficiently
sensitive to detect any differences, if they were present. We hope
that they are correct and that they, or others, will be successful
where we have failed. We remain very keen on using such a test in
future intervention trials.
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